We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current BMRA market cap is 12.24M. The company's latest EPS is USD -0.3260 and P/E is -2.06.
| Quarter End | Nov 2023 | Feb 2024 | May 2024 | Aug 2024 | Nov 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.57M | 1.02M | 1.12M | 1.81M | 1.64M |
| Operating Income | -1.61M | -2.06M | -1.53M | -1.37M | -995k |
| Net Income | -1.51M | -1.92M | -1.42M | -1.32M | -950k |
| Year End May 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 6.69M | 7.2M | 18.87M | 5.34M | 5.42M |
| Operating Income | -2.4M | -6.52M | -4.53M | -7.22M | -6.37M |
| Net Income | -2.34M | -6.47M | -4.53M | -7.14M | -5.98M |
| Quarter End | Nov 2023 | Feb 2024 | May 2024 | Aug 2024 | Nov 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 11.83M | 10.34M | 9.25M | 7.87M | 7.27M |
| Total Liabilities | 2.45M | 2.53M | 2.66M | 2.52M | 2.16M |
| Total Equity | 9.38M | 7.81M | 6.59M | 5.35M | 5.11M |
| Year End May 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 17.26M | 11.82M | 11.37M | 14.45M | 9.25M |
| Total Liabilities | 3.05M | 2.59M | 3.05M | 2.73M | 2.66M |
| Total Equity | 14.21M | 9.23M | 8.33M | 11.72M | 6.59M |
| Quarter End | Nov 2023 | Feb 2024 | May 2024 | Aug 2024 | Nov 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.52M | -4.32M | -5.36M | -1.34M | -2.14M |
| Investing | -75k | -91k | -115k | N/A | -33k |
| Financing | N/A | N/A | -81k | N/A | 380k |
| Year End May 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -4.3M | -5.25M | -481k | -5.44M | -5.36M |
| Investing | -119k | -295k | -170k | -78k | -115k |
| Financing | 12.37M | 1.11M | 2.4M | 9.39M | -81k |
| Market Cap | 12.24M |
| Price to Earnings Ratio | -2.06 |
| Price to Sales Ratio | 2.27 |
| Price to Cash Ratio | 2.95 |
| Price to Book Ratio | 1.86 |
| Dividend Yield | - |
| Shares Outstanding | 18.34M |
| Average Volume (1 week) | 897.41k |
| Average Volume (1 Month) | 1.43M |
| 52 Week Change | -48.66% |
| 52 Week High | 1.3399 |
| 52 Week Low | 0.2415 |
| Spread (Intraday) | 0.03 (4.8%) |
| Company Name | Biomerica Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.biomerica.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
